The neural correlates of placebo effects: a disruption account
By Matthew D. Lieberman, Johanna M. Jarcho, S. Berman, Bruce D. Naliboff, Brandall Y. Suyenobu, Mark A. Mandelkern, Emeran A. Mayer. NeuroImage, 2004
310 citations recorded by the source corpus.
Subfields: Cognitive Neuroscience, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/68e1a9e6333aff5cce337cb791c965330eedfec9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
- Kevin N. Ochsner
- James J. Gross
- Matthew D. Lieberman
- Tor D. Wager
- Naomi I. Eisenberger
- F. Benedetti
- Robert T. Knight
- C. Stohler
In Psychiatry and Mental health
- Robert T. Knight
- Christine Hooker
- Naomi I. Eisenberger
- Shelley E. Taylor
- Michael R. Irwin
- Matthew D. Lieberman
- James J. Gross
- Helen S. Mayberg
Citations in the corpus
- The neural architecture of emotion regulation (2007, background): “In keeping with this suggestion, Cunningham, Raye, and Johnson (2004) found right ventral lateral activation (LPFC) when making good/bad evaluations of attitude targets (e.g., abortion) on trials where they reported in postscan ratings that they had exerted control.”
- Neural pathways link social support to attenuated neuroendocrine stress responses (2007, background): “VLPFC has been shown to play a role in regulating the distress of physical pain and negative affect (Hariri et al., 2000; Lieberman et al., 2004; Lieberman, et al., in press; Ochsner et al., 2004; Petrovic and Ingvar, 2002).”
- The role of lateral orbitofrontal cortex in the inhibitory control of emotion (2006, background): “sation, which is then related to a decrease in self-reported pain symptoms (Petrovic and Ingvar 2002; Petrovic et al. 2002; Lieberman et al. 2004; Wager et al. 2004).”
- Social cognitive neuroscience: a review of core processes. (2007, background): “Given the symbolic nature of the self, it is not surprising that the regions involved in self-recognition have been linked with controlled processing.”
- Neurobiological Mechanisms of the Placebo Effect (2005, background): “Recently, the placebo effect has reemerged in the public and scientific interest because of investigations of its biological substrates (de la Fuente-Fernandez et al., 2001; Mayberg et al., 2002; Petrovic et al., 2002; Lieberman et al., 2004; Wager et al., 2004; Colloca and Benedetti, 2005; Zubieta ”
- Prefrontal-subcortical pathways mediating successful emotion regulation. (2008, unknown): “, 1997) and placebo treatments (Lieberman et al., 2004; Price et al., 2007; Wager et al., 2004b) that lead to reduced pain have consistently reduced rdACC activity.”
- An fMRI Study of Cytokine-Induced Depressed Mood and Social Pain: The Role of Sex Differences (2009, background): “Interestingly, activity in the rVLPFC, known to be involved in emotion and pain regulation (Eisenberger et al., 2003; Lieberman et al., 2004; Ochsner and Gross, 2005; Wager et al., 2004) correlated negatively with activation in the right anterior insula (34, 24, 14, r=− .”
- Activation of the opioidergic descending pain control system underlies placebo analgesia. (2009, background): “…demonstrated placebo-induced signal decreases in pain-sensitive brain regions, such as thalamus, insula, and dorsal anterior cingulate cortex (Bingel et al., 2006; Lieberman et al., 2004; Price et al., 2007; Wager et al., 2004), most likely related to the pain reduction experienced under placebo.”